FRA/RHO6 (FRA/RHO6)

Frankfurt Stock Exchange: FRA/RHO6 · EUR

€53.9

+0.06 (+0.1%)· Recorded snapshot

Market cap	344.4B
Revenue (ttm)	68.2B
Net income (ttm)	13.4B
EPS (ttm)	€2.07
P/E (trailing)	26.0x
P/E (forward)	18.7x
Dividend	€0.84 (1.57%)
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 68.2B
Net income (ttm): 13.4B
EPS (ttm): €2.07
P/E (trailing): 26.0x
P/E (forward): 18.7x
Market cap: 344.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.7

P25 n/aP50 n/aP75 n/a

Trailing P/E26

P25 n/aP50 n/aP75 n/a

ROE38.1

P25 n/aP50 n/aP75 n/a

ROIC28.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All FRA/RHO6 indicators

Market & fundamental data

Available fields

257

Groups with data

Currency

CHF

Showing 257 of 257 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Switzerland
Country code	DE
Earnings date	2026-10-28
Employees	103,249
Employees change	-356
Employees growth	-0.34%
Enterprise value	EUR 374.2B
Exchange	Frankfurt Stock Exchange
Financial currency	CHF
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1896
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US7711951043
Last earnings date	2026-07-23
Last refreshed	2026-10-28
Last stock split date	2014-02-27
Last stock split type	Forward
Market cap	EUR 344.4B
Next earnings date	2026-10-28
Price	EUR 53.85
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	fra/RHO6
Website	https://www.roche.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	20.44x
Average P/E ratio (3Y)	20.61x
Average P/E ratio (5Y)	20.31x
Earnings yield	3.85%
EV/Earnings	27.99x
EV/EBIT	16.62x
EV/EBITDA	14.29x
EV/FCF	21.94x
EV/Sales	5.5x
FCF / EV yield	4.56%
FCF yield	4.95%
Forward P/E	18.67x
Graham number	17.10265
Graham upside	-68.24%
Lynch fair value	EUR 10.45
Lynch upside	-80.59%
P/(FCF - SBC) ratio	21.36x
P/(OCF - SBC) ratio	17.17x
P/B ratio	8.66x
P/E ratio	25.96x
P/FCF ratio	20.19x
P/OCF ratio	16.4x
P/S ratio	5.05x
Price / tangible book value	56.73x
Price/EBITDA ratio	13.27x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.12%
EBITDA margin	38.06%
Effective tax rate	18.74%
FCF margin	25.04%
Gross margin	74.17%
Operating margin	33.12%
Pretax margin	25.98%
Profit margin	19.6%
Profit per employee	EUR 129,482
Profitable quarters	47
Profitable years	23
Revenue per employee	EUR 660,568
ROA	13.51%
ROA (5Y)	13.31%
ROCE	30.06%
ROE	38.11%
ROE (5Y)	38.06%
ROIC	28.1%
ROIC (5Y)	32.56%
SBC / revenue	1.38%
Tax / revenue	4.87%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	30.57%
EPS growth (Q)	-7.69%
EPS growth (QoQ)	25.11%
EPS growth 10Y	3.82%
EPS growth 3Y	3.87%
EPS growth 5Y	-1.14%
EPS growth years	1
FCF growth	-0.29%
FCF growth (Q)	11.9%
FCF growth (QoQ)	-37.37%
FCF growth 3Y	6.53%
FCF growth 5Y	-0.37%
Gross profit growth	-1.65%
Gross profit growth (Q)	-2.07%
Gross profit growth 3Y	0.36%
Gross profit growth 5Y	0.78%
Net income growth	30.88%
Net income growth (Q)	-7.27%
Net income growth (QoQ)	25.61%
Net income growth 3Y	3.82%
Net income growth 5Y	-2.52%
Net income growth years	1
OCF growth	0.56%
OCF growth (Q)	7.54%
OCF growth (QoQ)	-35.03%
OCF growth 10Y	3.05%
OCF growth 3Y	5.46%
OCF growth 5Y	-0.34%
Operating income growth	2.89%
Operating income growth (Q)	-0.94%
Operating income growth 3Y	3.16%
Operating income growth 5Y	1.78%
Revenue growth	-0.83%
Revenue growth (Q)	-1.25%
Revenue growth (QoQ)	-0.17%
Revenue growth 10Y	2.01%
Revenue growth 3Y	0.23%
Revenue growth 5Y	0.28%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -3.9B
Depreciation and amortization	EUR 3.4B
EBIT	EUR 22.6B
EBITDA	EUR 26B
EPS	EUR 2.07
Financing cash flow	EUR -14.5B
Free cash flow	EUR 17.1B
Free cash flow minus SBC	EUR 16.1B
Gross profit	EUR 50.6B
Income taxes	EUR 3.3B
Investing cash flow	EUR -8.6B
Net borrowing	EUR -2.1B
Net cash flow	EUR -2.3B
Net income	EUR 13.4B
Operating cash flow minus SBC	EUR 20.1B
Operating income	EUR 22.6B
Revenue	EUR 68.2B
Stock-based compensation	EUR 938.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.48
Book value per share	EUR 44.45
Debt / EBITDA	1.37
Debt / equity	0.91
Debt / FCF	2.11
Goodwill	EUR 8.4B
Interest coverage	18.24
Long-term assets	EUR 68B
Long-term liabilities	EUR 35.4B
Net cash (debt)	EUR -25.5B
Net cash / market cap	-7.42%
Net debt / EBITDA	0.98
Net debt / equity	0.64
Net debt / FCF	1.5
Piotroski F-Score	5
Property, plant and equipment	EUR 25.3B
Shareholders' equity	EUR 39.8B
Tangible book value	EUR 6.1B
Tangible book value per share	EUR 7.62
Total assets	EUR 106.4B
Total cash	EUR 10.5B
Total debt	EUR 36.1B
Total liabilities	EUR 66.6B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.65
Current assets	EUR 38.3B
Current liabilities	EUR 31.2B
Current ratio	1.23
Inventory turnover	2.07
Net working capital	EUR 3.7B
Quick ratio	0.8
Working capital	EUR 7.1B
Working capital turnover	9.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.31%
Dividend growth	4.3%
Dividend growth (10Y)	0.89%
Dividend growth (3Y)	3.5%
Dividend growth (5Y)	5.35%
Dividend growth years	4
Dividend payment date	2026-04-22
Dividend payment years	22
Dividend payout frequency	Annual
Dividend per share	EUR 0.84
Dividend yield	1.57%
Ex-dividend date	2026-03-13
Last dividend	EUR 0.84
Payout ratio	63.22%
Shareholder yield	1.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	106.89%
10Y return CAGR	9.92%
10Y total return	157.4%
150-day SMA	EUR 45.80
15Y price change	269.22%
15Y return CAGR	11.74%
15Y total return	428.82%
1D price change	0.11%
1M price change	13.2%
1M total return	13.2%
1W price change	6.57%
1W total return	6.57%
1Y price change	47.58%
1Y return CAGR	50.41%
1Y total return	50.37%
20-day SMA	EUR 49.43
200-day SMA	EUR 46.12
20Y price change	212.48%
20Y return CAGR	8.4%
20Y total return	401.44%
3M price change	14.33%
3M total return	14.33%
3Y price change	72.9%
3Y return CAGR	22.64%
3Y total return	84.49%
50-day SMA	EUR 48.21
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 53.85
52-week high date	2026-10-27
52-week low	EUR 34.32
52-week low date	2025-11-04
5Y price change	30.88%
5Y return CAGR	7.75%
5Y total return	45.2%
6M price change	22.15%
6M total return	22.15%
All-time high	EUR 53.85
All-time high date	2026-10-27
All-time low	EUR 9.39
All-time low date	2004-08-23
Average true range (ATR)	EUR 0.75
Average volume	91.4
Change from 52-week high	0%
Change from 52-week low	56.93%
Change from all-time high	0%
Change from all-time low	473.6%
Change from open	0.58%
Day's gap	-0.46%
High price	EUR 53.85
Low price	EUR 53.33
Monthly RSI	68.84
Open price	EUR 53.54
Position in 52-week range	100%
Previous close	EUR 53.79
Price vs 150-day SMA	17.59%
Price vs 20-day SMA	8.94%
Price vs 200-day SMA	16.77%
Price vs 50-day SMA	11.7%
Relative volume	0.2
RSI	75.54
Sharpe ratio	1.54
Sharpe ratio (3Y)	0.72
Sharpe ratio (5Y)	0.22
Sortino ratio	2.74
Sortino ratio (3Y)	1.34
Sortino ratio (5Y)	0.54
Volume	0
Weekly RSI	69.8
YTD price change	22.95%
YTD total return	25.27%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	723.7M
Shares change (QoQ)	0.5%
Shares change (YoY)	0.31%
Shares held by insiders	9.17%
Shares held by institutions	28.89%

Deeper analysis on FRA/RHO6

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FRA/RHO6 report

Is a complete FRA/RHO6 research report available?

No complete published report is available for fra/RHO6 (FRA/RHO6) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/RHO6 (FRA/RHO6)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/RHO6

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/RHO6 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRA/RHO6

Frequently asked questions